Journal of Bioanalysis & Biomedicine

5^th European Biosimilars Congress

June 27-29, 2016 Valencia, Spain

Keynote

• Interchangeability of biological drug products

  Laszlo Endrenyi

  PDF HTML

• Evaluating immunogenicity in biosimilars

  Candida Fratazzi

  PDF HTML

• Paradime shift in discovery & secretion of biosimilars via path breaking innovation

  Pawan Saharan

  PDF HTML

• FDA/EMA current thinking on totality of evidence for biosimilar approvals

  Kamali Chance

  PDF HTML

• Lean bioproduction of biosimilars for small to mid-size pharma companies

  Andreu Soldevila

  PDF HTML

• Establishing Finger-print Like biosimilarity-critical characterization steps for biosimilar assessment

  Fiona M Greer

  PDF HTML

• Overcoming the challenges of biosimilar development as a mid-size player

  Ruediger Jankowsky

  PDF HTML